B-luc-GFP Raji_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen, drug development, antibody discovery

Please input keywords

Order

*Country

한국

미국

일본

중국

영국

호주

프랑스

독일

이탈리아

싱가포르

인도

러시아

캐나다

스위스

기타 국가

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

B-luc-GFP Raji

Common name	B-luc-GFP Raji	Catalog number	310670
Aliases	NA	Disease	Burkitt's lymphoma
Organism	Human	Strain	NA
Tissue types	Lymphoma	Tissue	Lymphoblast

Description

This B-luc-GFP Raji cell line expresses firefly luciferase as a marker of Raji cells. Luminescence can be observed B-luc-GFP Raji cells.

Application

B-luc-GFP Raji cell line can be used to evaluate anti-cancer drugs in burkitt's lymphoma in vivo.

Phenotypic Analysis

from clipboard

Phenotypic analysis of B-luc-GFP Raji.

A. Fluorescence microscopy imaging showed green fluorescent expression in B-luc-GFP Raji;

B. The results showed that the fluorescence intensity of B-luc-GFP Raji cells was significantly higher than that of the control group. The expression of luciferase was detected by Bright-GloTM luciferase Assay System (Promega, Cat E2610).

Imaging analysis in vivo

from clipboard

Quantitative imaging data & body weight changes

from clipboard

Tumor growth and in vivo imaging of B-luc-GFP Raji cells. B-luc-GFP Raji cells (1x10⁶) were injected by tail vein into B-NDG mice .Signal intensity and body weight were measured twice a week. (A) Imaging was performed on days 0, 4, 6, 8, 11, 15, and 18 , (B) Mice body weight (Mean ± SEM). B-luc-GFP Raji cells can be used for in vivo efficacy evaluation.

Human CD47Ab efficacy based on B-NDG mice

from clipboard

B-luc-GFP Raji cells were injected intraperitoneally into B-NDG and observed with a small animal imager. The animals were enrolled into the control group and the treatment group (n=6) when the tumor fluorescence intensity reached 1.5E6.

The results showed that different anti-human CD47 antibodies had different inhibitory effects on tumor growth at the same dose. A. Tumor fluorescence intensity ± SEM, B. Mean body weight ± SEM.